More Data, Fewer Antibiotics Are Keys to Fighting Deadly Superbugs (WELLNESS)
As our lawmakers in the Senate discuss the fees that companies will pay to help the FDA expedite drug reviews, they should also require those companies to provide information that helps the agency protect people from drug-resistant superbugs.